alendronate and sulfasalazine

alendronate has been researched along with sulfasalazine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ballester, I; Daddaoua, A; López-Posadas, R; Martínez-Augustin, O; Nieto, A; Sánchez de Medina, F; Suárez, MD; Zarzuelo, A1
Liu, XY; Zhang, LL; Zhao, JX1
Ahmed, K; Khan, I; Mohiuddin, T; Rohman, N; Selvaraj, R; Skelton, AA; Yamin, M1

Reviews

1 review(s) available for alendronate and sulfasalazine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for alendronate and sulfasalazine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in rats.
    British journal of pharmacology, 2007, Volume: 151, Issue:2

    Topics: Administration, Oral; Alendronate; Animals; Anti-Inflammatory Agents; Body Weight; Bone Density Conservation Agents; Chemokine CCL2; Colitis; Colon; Diphosphonates; Dose-Response Relationship, Drug; Female; Gastrointestinal Agents; Gene Expression; Injections, Intraperitoneal; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Rats; Rats, Wistar; Sulfasalazine; Treatment Outcome; Trinitrobenzenesulfonic Acid

2007
Successful treatment of SAPHO syndrome with severe spinal disorder using entercept: a case study.
    Rheumatology international, 2012, Volume: 32, Issue:7

    Topics: Acquired Hyperostosis Syndrome; Alendronate; Antirheumatic Agents; Bone Density Conservation Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Middle Aged; Pain Management; Radiography; Receptors, Tumor Necrosis Factor; Spinal Diseases; Sulfasalazine; Treatment Outcome

2012
Theoretical insights and implications of pH-dependent drug delivery systems using silica and carbon nanotube.
    Journal of molecular graphics & modelling, 2023, Volume: 125

    Topics: Acetaminophen; Alendronate; Drug Delivery Systems; Hydrogen-Ion Concentration; Ibuprofen; Nanotubes, Carbon; Quartz; Silicon Dioxide; Sulfasalazine

2023